240 related articles for article (PubMed ID: 36505813)
21. Construction and validation of a prognostic model for colon adenocarcinoma based on bile acid metabolism-related genes.
Luo Q; Zhou P; Chang S; Huang Z; Zeng X
Sci Rep; 2023 Aug; 13(1):12728. PubMed ID: 37543674
[TBL] [Abstract][Full Text] [Related]
22. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
Xu M; Mu J; Wang J; Zhou Q; Wang J
Front Oncol; 2022; 12():961213. PubMed ID: 35965536
[TBL] [Abstract][Full Text] [Related]
23. Identification and Validation of Immune-Related Prognostic Genes in the Tumor Microenvironment of Colon Adenocarcinoma.
Pan S; Tang T; Wu Y; Zhang L; Song Z; Yu S
Front Genet; 2021; 12():778153. PubMed ID: 35047006
[TBL] [Abstract][Full Text] [Related]
24. Glucose metabolism-based signature predicts prognosis and immunotherapy strategies for colon adenocarcinoma.
Bai Z; Yan C; Nie Y; Zeng Q; Xu L; Wang S; Chang D
J Gene Med; 2024 Jan; 26(1):e3620. PubMed ID: 37973153
[TBL] [Abstract][Full Text] [Related]
25. Construction of a prognostic model for colorectal adenocarcinoma based on Zn transport-related genes identified by single-cell sequencing and weighted co-expression network analysis.
Chen H; Zhao T; Fan J; Yu Z; Ge Y; Zhu H; Dong P; Zhang F; Zhang L; Xue X; Lin X
Front Oncol; 2023; 13():1207499. PubMed ID: 37829346
[TBL] [Abstract][Full Text] [Related]
26. A novel necroptosis-related gene signature associated with immune landscape for predicting the prognosis of papillary thyroid cancer.
Wang Z; Wu P; Shi J; Ji X; He L; Dong W; Wang Z; Zhang H; Sun W
Front Genet; 2022; 13():947216. PubMed ID: 36186479
[No Abstract] [Full Text] [Related]
27. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.
Wang L; Wang L; He P
Front Genet; 2022; 13():1064432. PubMed ID: 36568383
[No Abstract] [Full Text] [Related]
28. Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis.
Huang Y; Huang C; Jiang X; Yan Y; Zhuang K; Liu F; Li P; Wen Y
Front Genet; 2022; 13():816173. PubMed ID: 35281843
[No Abstract] [Full Text] [Related]
29. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
Sun K; Huang C; Li JZ; Luo ZX
World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
[TBL] [Abstract][Full Text] [Related]
30. Unraveling the role of disulfidptosis-related LncRNAs in colon cancer: a prognostic indicator for immunotherapy response, chemotherapy sensitivity, and insights into cell death mechanisms.
Chi H; Huang J; Yan Y; Jiang C; Zhang S; Chen H; Jiang L; Zhang J; Zhang Q; Yang G; Tian G
Front Mol Biosci; 2023; 10():1254232. PubMed ID: 37916187
[No Abstract] [Full Text] [Related]
31. The implication of necroptosis-related lncRNAs in orchestrating immune infiltration and predicting therapeutic efficacy in colon adenocarcinoma: an integrated bioinformatic analysis with preliminarily experimental validation.
Li S; Wang X; Liu Y; Xiao J; Yi J
Front Genet; 2023; 14():1170640. PubMed ID: 37600653
[No Abstract] [Full Text] [Related]
32. Identification of sixteen metabolic genes as potential biomarkers for colon adenocarcinoma.
Zhao F; Liu Y; Gu X; Zhang B; Song C; Cui B
J BUON; 2021; 26(4):1252-1259. PubMed ID: 34564978
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance and immune landscape of a fatty acid metabolism-related gene signature in colon adenocarcinoma.
Liu X; Fang X; Lu L; Liu G
Front Genet; 2022; 13():996625. PubMed ID: 36568396
[No Abstract] [Full Text] [Related]
34. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
35. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis.
Liang X; Cheng Z; Chen X; Li J
Front Genet; 2022; 13():955424. PubMed ID: 36046241
[No Abstract] [Full Text] [Related]
36. Identification of DLL3-related genes affecting the prognosis of patients with colon adenocarcinoma.
Xiang J; Gong W; Liu J; Zhang H; Li M; Wang R; Lv Y; Sun P
Front Genet; 2023; 14():1098190. PubMed ID: 37274780
[No Abstract] [Full Text] [Related]
37. Development of necroptosis-related gene signature to predict the prognosis of colon adenocarcinoma.
Li M; Zhang T; Chen W
Front Genet; 2022; 13():1051800. PubMed ID: 36353119
[TBL] [Abstract][Full Text] [Related]
38. Development of a prognostic model for personalized prediction of colon adenocarcinoma (COAD) patient outcomes using methylation-driven genes.
Chen D; Zhang B; Kang K; Li L; Liao Y; Qing S; Di Y
J Appl Genet; 2023 Dec; 64(4):713-721. PubMed ID: 37589877
[TBL] [Abstract][Full Text] [Related]
39. A novel enterocyte-related 4-gene signature for predicting prognosis in colon adenocarcinoma.
Cheng X; Wei Y; Fu Y; Li J; Han L
Front Immunol; 2022; 13():1052182. PubMed ID: 36532007
[TBL] [Abstract][Full Text] [Related]
40. Novel characterization discoveries of ferroptosis-associated molecules in COAD microenvironment based TCGA data.
Baldi S; He Y; Ivanov I; Sun Y; Feng W; Refat M; Mohammed SAD; Adlat S; Tian Z; Wang Y; Gao Y; Tian H
Front Mol Biosci; 2022; 9():1102735. PubMed ID: 36582202
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]